HALLUCINATION AND RISK FACTORS IN PATIENTS WITH PARKINSON’S DISEASE

dc.contributor.authorSay, Bahar
dc.contributor.authorÜnal, Yasemin
dc.contributor.authorTunç, Tuğba
dc.contributor.authorErgun, Ufuk
dc.contributor.authorErgün, Ufuk
dc.date.accessioned2025-01-21T16:18:38Z
dc.date.available2025-01-21T16:18:38Z
dc.date.issued2019
dc.departmentKırıkkale Üniversitesi
dc.description.abstractObjective: Hallucination is one of the non-motor symptoms inParkinson disease (PD). Several factors may affect the presenceof hallucination. In the present study, we aimed to compare PDpatients presenting with and without hallucinations, to determinerisk factors, and to find out common hallucination types.Material and Methods: Idiopathic Parkinson patients regardingto UK Parkinson Disease Society Brain Bank with and withouthallucinations were compared. The patients with psychoticsymptoms due to metabolic, infectious, and structural causeswere excluded. Disease severity was evaluated by UnifiedParkinson Disease Rating Scale and Hoehn and Yahr staging.Cognitive status was assessed by Minimental State Examinationtest. Depression was diagnosed on the basis of DSM-V Tr.Description of hallucination, treatment, co-morbidity, sleepdisturbances, REM sleep behavioral disorder, age, gender,scores of test and scale, stage of disease were recorded.Results: A total of 91 (59 female, 32 male) patients withidiopathic PD were enrolled. The group with hallucinations(Group 1) had 40 (43.9%) patients and the one withouthallucinations (Group 2) had 51 (54.9%) patients. Total score ofUnified Parkinson Disease Rating Scale was significantly higherin Group 1 than Group 2 (37.83±16.65; 30.18±14.83; p=0.028).Sleep disturbances were high in Group 1 (n=24, 60%) whencompared to Group 2 (n=14, 27.4%) (p=0.007). The meanduration of hallucinations was 24.87±56.47 months in Group 1.Twenty-one patients (23.9%) had visual hallucinations; 15(16.5%) patients had illusions (minor hallucinations); and four(4.4%) patients had auditory hallucinations.Conclusion: Disease severity in Parkinson's disease may be afactor in the presence of hallucinations. Hallucinations may alsooccur with sleep disorders. Minor hallucinations are frequentlyobserved in early stages, with visual hallucinations being themost common hallucinations that may occur in every diseasestage.
dc.identifier.doi10.24938/kutfd.619939
dc.identifier.endpage394
dc.identifier.issn2148-9645
dc.identifier.issue3
dc.identifier.startpage388
dc.identifier.trdizinid415791
dc.identifier.urihttps://doi.org/10.24938/kutfd.619939
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/415791
dc.identifier.urihttps://hdl.handle.net/20.500.12587/22911
dc.identifier.volume21
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofKırıkkale Üniversitesi Tıp Fakültesi Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectNörolojik Bilimler
dc.subjectPsikiyatri
dc.titleHALLUCINATION AND RISK FACTORS IN PATIENTS WITH PARKINSON’S DISEASE
dc.typeArticle

Dosyalar